BMRC
Guglielmetti Lab
The Guglielmetti Lab seeks to develop and characterize innovative magnetic resonance (MR) and position emission tomography (PET) imaging approaches for the study of neurological disorders and monitoring of novel therapies. Using advanced neuroimaging methods, our goal is to determine biological mechanisms involved in neurological disease onset and progression, and to provide noninvasive biomarkers of disease and treatment response.
Our People
The lab, led by Caroline Guglielmetti, PhD, consists of a collaborative and interdisciplinary team with expertise in neurosciences, PET and MR molecular imaging, and immunology.
Projects
Our lab develops innovative PET and MRI approaches, including hyperpolarized MR spectroscopy, to study metabolic alterations in small animal models of disease. Research projects focus on using a multimodal approach to monitor neuroinflammation, neurodegeneration and repair mechanisms in neurological disorders, with an emphasis on multiple sclerosis.
